Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (24) Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (2) Pezzutto, Antonio Prof. Dr. (2) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (8) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Dr. (4) 2006 (1) (-) 2007 (1) (-) 2008 (1) (-) 2010 (1) 2011 (1) 2013 (3) (-) 2015 (2) (-) 2016 (3) 2017 (1) 2018 (3) 2020 (1) 2022 (1) Cardiac MRI (2) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (7) Genetics and Genomics of Cardiovascular Diseases (1) Genetics of Metabolic and Reproductive Disorders (3) Genome Diversification & Integrity (1) Genome Engineering & Disease Models (4) Genomics (2) Immune Regulation and Cancer (7) Macromolecular Structure and Interaction (1) Mathematical Modelling of Cellular Processes (1) Mobile DNA (1) Molecular Cell Biology and Gene Therapy (13) (-) Molecular Immunology and Gene Therapy (8) Protein Production & Characterization Platform (1) Proteome Dynamics (3) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) Proteomics Metabolomics (1) RNA Biology and Posttranscriptional Regulation (4) Signal Transduction in Development and Cancer (1) Signal Transduction in Tumor Cells (1) Systems Biology of Gene Regulatory Elements (1) 8 Results: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Dr.Molecular Immunology and Gene Therapy20072008201020152016 Sort: Result score Newest to oldest Oldest to newest October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
